Skip to main content
Log in

No need for NMDA receptor antibody screening in neurologically asymptomatic patients with ovarian teratomas

  • Letter to the Editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Prat J, FIGO Committee on Gynecologic Oncology (2014) Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet 124:1–5

    Article  PubMed  Google Scholar 

  2. Titulaer MJ, McCracken L, Gabilondo I, Armangue T, Glaser C, Iizuka T, Honig LS, Benseler SM, Kawachi I, Martinez-Hernandez E, Aguilar E, Gresa-Arribas N, Ryan-Florance N, Torrents A, Saiz A, Rosenfeld MR, Balice-Gordon R, Graus F, Dalmau J (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12:157–165

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Gong S, Zhou M, Shi G, Guo J, Chen N, Yang R, He L, Zhou D (2017) Absence of NMDA receptor antibodies in patients with ovarian teratoma without encephalitis. Neurol Neuroimmunol Neuroinflamm 4:e344

    Article  PubMed  PubMed Central  Google Scholar 

  4. Mangler M, Trebesch de Perez I, Teegen B, Stocker W, Pruss H, Meisel A, Schneider A, Vasiljeva J, Speiser D (2013) Seroprevalence of anti-N-methyl-d-aspartate receptor antibodies in women with ovarian teratoma. J Neurol 260:2831–2835

    Article  CAS  PubMed  Google Scholar 

  5. Chan JK, Brady MF, Penson RT, Huang H, Birrer MJ, Walker JL, DiSilvestro PA, Rubin SC, Martin LP, Davidson SA, Huh WK, O’Malley DM, Boente MP, Michael H, Monk BJ (2016) Weekly vs. every-3-week paclitaxel and carboplatin for ovarian cancer. N Engl J Med 374:738–748

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joachim Havla.

Ethics declarations

Conflicts of interest

The authors report no conflict of interest with regard to this study.

Ethical standard

The study was approved by the local ethics committee (University Medical Center Hamburg–Eppendorf) in compliance with the Declaration of Helsinki.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 15 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Trillsch, F., Eichhorn, P., Oliveira-Ferrer, L. et al. No need for NMDA receptor antibody screening in neurologically asymptomatic patients with ovarian teratomas. J Neurol 265, 431–432 (2018). https://doi.org/10.1007/s00415-017-8717-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-017-8717-3

Navigation